Kineta, Inc. (KANT)
OTCMKTS
· Delayed Price · Currency is USD
0.412
-0.008 (-1.83%)
Dec 20, 2024, 4:00 PM EST
Kineta Employees
As of December 31, 2023, Kineta had 13 total employees, including 11 full-time and 2 part-time employees. The number of employees increased by 1 or 8.33% compared to the previous year.
Employees
13
Change (1Y)
1
Growth (1Y)
8.33%
Revenue / Employee
n/a
Profits / Employee
-$1,439,833
Market Cap
5.06M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 13 | 1 | 8.33% |
| Dec 31, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sandoz Group AG | 22,633 |
| Telix Pharmaceuticals Limited | 234 |
| Elekta AB (publ) | 4,718 |
| Ryman Healthcare Limited | 7,700 |
| Verano Holdings Corp. | 3,900 |
| Vireo Growth Inc. | 490 |
| Medexus Pharmaceuticals Inc. | 82 |
Kineta News
- 8 days ago - SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Kineta, Inc. - KANT - PRNewsWire
- 8 days ago - KANT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kineta, Inc. Is Fair to Shareholders - Business Wire
- 6 weeks ago - Kineta Updates KVA12123 Clinical Results from Ongoing Phase 1/2 VISTA101 Study at Society for Immunotherapy of Cancer (2024) - GlobeNewsWire
- 2 months ago - Kineta Announces KVA12123 Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024 - GlobeNewsWire
- 2 months ago - Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta's VISTA blocking antibody Currently in Phase 1 - GlobeNewsWire
- 3 months ago - Kineta, Inc Transitioning from Nasdaq to OTC Markets - GlobeNewsWire